# US 2017/0290990 A1 · Injector lockout prevention device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0290990 A1
- Document ID: US20170290990A1
- Status: Published application
- Kind: A1
- Application number: 15/484,642
- Filed: 2017-04-11
- Published: 2017-10-12
- Earliest claimed: 2016-04-11
- Assignees: Biogen MA Inc.
- Applicants: Biogen MA Inc.
- Inventors: Haiming Wu
- Web page: https://patentgrep.com/patent/US20170290990A1

## CPC

- A61M 5/3204: {Needle cap removers, i.e. devices to dislodge protection cover from needle or needle hub, e.g. deshielding devices}
- A61M 5/2033: {Spring-loaded one-shot injectors with or without automatic needle insertion (multishot dosing syringes A61M5/31525, needle insertion only A61M5/3287)}
- A61M 5/31578: {the piston rod being moved by the axial movement of a component directly in contact with it}
- A61M 5/326: {Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user}
- A61M 2005/2073: {preventing premature release, e.g. by making use of a safety lock}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A device that prevents the accidental activation and lockout of an autoinjector. In illustrative embodiments, a resistance unit is configured to resist deployment of the needle until a critical force is applied by the user to the autoinjector, at which point, the resistance of the resistance unit is overcome. Continuous application of force by the user after the resistance is overcome drives the delivery device to the injection site where the medication is administered.

## Claims

### Claim 1

A lockout prevention device to control the injection of a syringe of an autoinjector, the autoinjector having a housing and a needle guard, the lockout prevention device comprising:
a resistance unit connected to the autoinjector;
the resistance unit is configured to have a first position, wherein the resistance unit prevents the needle guard from exposing the syringe to an injection site, and a second position, wherein the resistance unit does not prevent the needle guard from exposing the syringe to the injection site; and
wherein an injection force, required to expose the syringe to the injection site, is transmitted by application of a critical force to the autoinjector, which is required to move the resistance unit from the first position to the second position.

### Claim 2 (depends on 1)

The lockout prevention device of claim 1, wherein the resistance unit is connected to an end of the needle guard and comprises a ring and a base.

### Claim 3 (depends on 2)

The lockout prevention device of claim 2, wherein the base comprises an annular end wall and a skirt extending from the annular end wall.

### Claim 4 (depends on 3)

The lockout prevention device of claim 3, wherein the ring includes at least one protrusion that is configured to be received by the skirt, wherein the skirt comprises cantilevered arms extending from the base, and wherein the cantilevered arms comprise at least one recess for receiving the at least one protrusion in the first position.

### Claim 5 (depends on 4)

The lockout prevention device of claim 4, wherein movement of the resistance unit from the first position into the second position, by applying a critical force to the autoinjector, releases the at least one protrusion from the cantilevered arms.

### Claim 6 (depends on 5)

The lockout prevention device of claim 5, wherein, in the second position, application of the injection force to the autoinjector causes the needle guard to trigger the syringe to be exposed to the injection site; and wherein the injection force is less than the critical force.

### Claim 7 (depends on 1)

The lockout prevention device of claim 1, wherein the resistance unit comprises at least one cantilevered spring arm formed integrally in one piece with the needle guard, and wherein the at least one cantilevered spring arm comprises a protrusion on a distal end thereof.

### Claim 8 (depends on 7)

The lockout prevention device of claim 7, wherein, in the first position, the protrusion abuts a distal end of the housing, and, in the second position, the protrusion does not abut the distal end of the housing.

### Claim 9 (depends on 8)

The lockout prevention device of claim 8, wherein applying the critical force to the autoinjector releases the protrusion from the distal end of the housing, thereby moving the resistance unit into the second position.

### Claim 10 (depends on 1)

The lockout prevention device of claim 1, wherein the resistance unit is connected to an end of the needle guard and comprises a base, wherein the base comprises a skirt having a protrusion on a distal end thereof that abuts a distal end of the housing in the first position, and wherein, in the second position, the protrusion does not abut the distal end of the housing.

### Claim 11 (depends on 10)

The lockout prevention device of claim 10, wherein applying the critical force to the autoinjector releases the protrusion from the distal end of the housing, thereby moving the resistance unit into the second position.

### Claim 12 (depends on 1)

The lockout prevention device of claim 1, wherein the autoinjector device further comprises an end cap for selectively covering a distal end of the housing and the needle guard.

### Claim 13 (depends on 1)

The lockout prevention device of claim 1, wherein the syringe is carried by a delivery device.

### Claim 14

An autoinjector device, comprising:
a housing;
a delivery device disposed within, and moveable relative to, the housing, wherein the delivery device comprises a syringe;
an needle guard coupled to the syringe and configured to move the syringe through the housing to an injection site;
a resistance unit configured to have a first position, wherein the resistance unit prevents the needle guard from exposing the syringe to an injection site, and a second position, wherein the resistance unit does not prevent the needle guard from exposing the syringe to an injection site; and
wherein an injection force, required to expose the syringe to the injection site, is transmitted by application of a deployment force to the autoinjector, which is required to move the resistance unit from the first position to the second position.

### Claim 15 (depends on 14)

The lockout prevention device of claim 14, wherein the resistance unit is connected to an end of the needle guard and comprises a ring and a base.

### Claim 16 (depends on 15)

The lockout prevention device of claim 15, wherein the base comprises an annular end wall and a skirt extending from the annular end wall.

### Claim 17 (depends on 16)

The lockout prevention device of claim 16, wherein the ring includes at least one protrusion that is configured to be received by the skirt, wherein the skirt comprises cantilevered arms extending from the base, and wherein the cantilevered arms comprise at least one recess for receiving the at least one protrusion in the first position.

### Claim 18 (depends on 17)

The lockout prevention device of claim 17, wherein movement of the resistance unit from the first position into the second position, by applying a critical force to the autoinjector, releases the at least one protrusion from the cantilevered arms.

### Claim 19 (depends on 17)

The lockout prevention device of claim 17, wherein, in the second position, application of the injection force to the autoinjector causes the needle guard to expose the syringe to the injection site; and wherein the injection force is less than the critical force.

### Claim 20 (depends on 14)

The lockout prevention device of claim 14, wherein the resistance unit comprises at least one cantilevered spring arm formed integrally in one piece with the needle guard, and wherein the at least one cantilevered spring arm comprises a protrusion on a distal end thereof.

### Claim 21 (depends on 20)

The lockout prevention device of claim 20, wherein, in the first position, the protrusion abuts a distal end of the housing, and, in the second position, the protrusion does not abut the distal end of the housing.

### Claim 22 (depends on 21)

The lockout prevention device of claim 21, wherein applying the critical force to the autoinjector releases the protrusion from the distal end of the housing, thereby moving the resistance unit into the second position.

### Claim 23 (depends on 14)

The lockout prevention device of claim 14, wherein the resistance unit is connected to an end of the needle guard and comprises a base, wherein the base comprises a skirt having a protrusion on a distal end thereof that abuts a distal end of the housing in the first position, and wherein, in the second position, the protrusion does not abut the distal end of the housing.

### Claim 24 (depends on 23)

The lockout prevention device of claim 23, wherein applying the critical force to the autoinjector releases the protrusion from the distal end of the housing, thereby moving the resistance unit into the second position.

### Claim 25 (depends on 14)

The lockout prevention device of claim 14, wherein the autoinjector device further comprises an end cap for selectively covering a distal end of the housing and the needle guard.
